Barclays »

Rani Therapeutics Hldgs shares owned by Barclays

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by Barclays

Quarter filed Position value Share count Share price at filing
2025-12-31 $11k 8.1k 1.35
2024-03-31 $0 39 0.00

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Microsoft Corp Opt Put Option (MSFT)
Apple (AAPL)
Ishares Tr Opt Call Option (IWM)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Tesla Motors (TSLA)
Facebook Inc cl a (META)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Ishares Tr Opt Put Option (HYG)
Advanced Micro Devices (AMD)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding Rani Therapeutics Hldgs

Samsara BioCapital
AWM Investment Company
Vanguard Group
Susquehanna International
Siren
Jane Street
Geode Capital Management
BlackRock
Nan Fung Group Holdings
683 Capital Management
Citadel Advisors
State Street Corporation
Squarepoint Ops
United Services Automobile Association
Goldman Sachs Group

View all funds holding Rani Therapeutics Hldgs